1. Introduction 

The Brain-Market Governance Doctrine is a proposed legal and regulatory framework for governing markets involving brain-related technologies, neural data, brain–computer interfaces (BCIs), neurotechnology services, cognitive enhancement, and products that infer or influence human mental states.

Its central question is:

How should the law regulate commercial activities involving the human brain while protecting mental privacy, autonomy, human dignity, informed consent, and fair competition?

The term Brain-Market Governance Doctrine is not, by itself, a universally recognized or established legal doctrine. It is best understood as an emerging interdisciplinary concept that draws on constitutional law, privacy and data protection, medical ethics, product liability, consumer protection, intellectual property, and competition law.

For example, a company might sell a wearable neural device that measures brain signals, an employer might consider using neurotechnology to monitor worker attention, or a technology platform might market a system that infers emotions or cognitive states. Each activity raises different legal questions about consent, data ownership and use, discrimination, commercial exploitation, and regulatory oversight.

2. Objectives of the doctrine

The proposed doctrine has seven principal objectives.

Protection of mental privacy: Prevent unauthorized collection, disclosure, or commercial exploitation of neural data and inferred mental states.

Cognitive liberty: Protect individuals against unjustified interference with their ability to think, decide, and control their mental processes.

Informed consent: Ensure that individuals understand what a neurotechnology system collects, what it can infer, and how the resulting information will be used.

Market fairness: Prevent monopolistic control over essential neurotechnology infrastructure, neural datasets, and compatible devices.

Consumer and patient protection: Address misleading performance claims, unsafe devices, defective products, and undisclosed risks.

Non-discrimination: Reduce the risk that neural measurements or cognitive inferences will be used unfairly in employment, education, insurance, credit, or public services.

Accountability: Establish clear responsibilities for manufacturers, service providers, data controllers, healthcare professionals, employers, and regulators.

These objectives must be balanced. A governance system should not prohibit beneficial medical research or assistive devices merely because they involve the brain. It should instead impose safeguards proportionate to the risks, purposes, and degree of control exercised over individuals.

3. Core legal principles

The proposed doctrine can be developed through six interrelated principles.

A. Mental privacy and neural-data protection

Neural data may reveal or support inferences about attention, sensory processing, health, emotional responses, or other aspects of a person's mental activity. The extent to which such inferences are reliable varies significantly by technology and context.

A governance framework should therefore distinguish between:

Raw neural signals collected by a device.

Medical interpretations of those signals.

Algorithmically inferred mental or behavioural characteristics.

Commercial profiles derived from combining neural data with other personal information.

A company should not automatically acquire unrestricted rights to use these categories simply because a consumer purchased its device.

The OECD's recent analysis of neurodata governance highlights risks to privacy, autonomy, and security, particularly where information can be inferred without the person's deliberate disclosure.

OECD+1

B. Cognitive liberty and freedom of thought

Cognitive liberty concerns a person's freedom to control their mental processes and to resist unjustified interference with them.

In commercial markets, this principle may be relevant when a product:

Attempts to alter cognitive activity.

Monitors attention or emotional responses.

Uses neural feedback to influence behaviour.

Makes access to employment or a service conditional on accepting neural monitoring.

However, cognitive liberty is not a single, universally codified legal right under that name. Its protection depends on the applicable constitution, legislation, and established rights.

C. Informed consent and meaningful choice

Consent should be specific, informed, and appropriate to the proposed use. A person agreeing to use a neurotechnology device for rehabilitation has not necessarily agreed to have the resulting data sold to advertisers or used to evaluate job performance.

A sound regulatory framework should require clear disclosure of:

What information is collected.

What mental or health-related inferences may be generated.

Who receives the information.

Whether the information is used to train commercial AI systems.

How consent can be withdrawn and what happens to stored data.

Consent also has limitations. Where a worker, patient, student, or dependent person faces substantial pressure, a signed form alone may not establish a genuinely voluntary choice.

D. Competition and market fairness

Brain-related technology markets may develop substantial entry barriers because of proprietary devices, exclusive datasets, patents, specialised clinical infrastructure, and network effects.

Potential competition concerns include exclusive licensing, discriminatory access to interfaces, tying devices to proprietary services, and preventing customers from switching providers.

The doctrine should not presume that every exclusive arrangement or patent is unlawful. It should ask whether the conduct harms competition, consumers, innovation, or access to essential services under the relevant competition law.

E. Product safety and professional responsibility

A defective neural device, an inaccurate diagnostic claim, or a poorly designed stimulation system can create physical, psychological, financial, or informational harm.

Potentially applicable legal duties include product safety, medical-device regulation, negligence, professional standards, warranty obligations, and consumer protection. The governing rules depend on whether the product is a medical device, a consumer wellness product, or another type of technology.

F. Transparency and accountability

Manufacturers and service providers should be able to explain the intended purpose of their systems, their limitations, relevant risks, and their procedures for handling complaints.

For high-risk applications, a proposed governance framework could require independent testing, documented risk assessments, security audits, human review of consequential decisions, and effective remedies for affected individuals.

4. Important case laws

There is no reported judgment establishing a single, comprehensive Brain-Market Governance Doctrine. The following cases provide legal foundations or useful analogies for particular parts of the proposed framework.

Case 1. Selvi v. State of Karnataka (2010)

Supreme Court of India · (2010) 7 SCC 263 · Decided 5 May 2010

Facts: The case concerned the involuntary administration of narcoanalysis, polygraph examinations, and the Brain Electrical Activation Profile (BEAP) test during criminal investigations.

Legal issue: Whether involuntary administration of these techniques violated constitutional protections against compelled self-incrimination and infringed personal liberty.

Decision: The Supreme Court held that involuntary administration of the impugned techniques violated Article 20(3) and the protection of personal liberty under Article 21. The Court also addressed the importance of mental privacy and the individual's control over personal testimony.

Sci API+1

Relevance to the doctrine: This is one of the most directly relevant Indian precedents because it specifically concerns a technique designed to obtain information associated with brain activity.

Its implications include:

The state cannot disregard constitutional safeguards merely because an investigative technique is described as scientific.

Bodily or mental intrusions must be assessed in light of individual liberty and constitutional protections.

The use of brain-related technology requires careful consideration of voluntariness and the nature of the information obtained.

Limitation: Selvi concerns specified investigative techniques and constitutional protections. It does not establish a general prohibition on commercial neurotechnology or decide who owns neural data in a private marketplace.

Case 2. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

Supreme Court of India · (2017) 10 SCC 1 · Decided 24 August 2017

Facts: A nine-judge Constitution Bench considered whether privacy is protected as a fundamental right under the Indian Constitution.

Legal issue: Whether privacy is constitutionally protected, including against unjustified interference with personal autonomy and informational privacy.

Decision: The Court unanimously recognised privacy as a fundamental right protected by Article 21 and the freedoms guaranteed by Part III of the Constitution. The judgment also articulated the legality, legitimate-aim, and proportionality requirements for assessing invasions of privacy.

NHRC+1

Relevance to the doctrine: This judgment supplies a major constitutional foundation for regulating brain-related commercial markets in India.

For example, a government programme requiring workers to wear neural-monitoring devices could raise questions about:

Whether the interference is authorised by law.

Whether the purpose is legitimate.

Whether the monitoring is necessary and proportionate.

Whether less intrusive alternatives exist.

The judgment also supports the broader argument that informational privacy deserves legal protection when personal information is collected and analysed at scale.

Limitation: Puttaswamy did not specifically determine the legal status of neural data or establish a freestanding constitutional right to cognitive liberty.

Case 3. Justice K.S. Puttaswamy (Retd.) v. Union of India — Aadhaar judgment (2018)

Supreme Court of India · (2019) 1 SCC 1 · Judgment delivered 26 September 2018

Legal issue: Whether the Aadhaar identification framework and related data practices were constitutionally valid.

Principle: The Court assessed the statutory framework, privacy implications, and proportionality of the identification system, upholding some aspects while invalidating or restricting others.

Relevance to the doctrine: The judgment provides a useful analogy for assessing large-scale systems that collect sensitive personal information and use it to determine access to services.

A future brain-market dispute might involve a company or public authority conditioning access to an essential service on the disclosure of neural information. The Aadhaar judgment would provide relevant constitutional reasoning, although the precise outcome would depend on the facts and governing law.

Limitation: The case concerns identity infrastructure, not neurotechnology. It should be used as an analogy rather than cited as a ruling on neural-data ownership.

Case 4. Montgomery v. Lanarkshire Health Board (2015)

UK Supreme Court · [2015] UKSC 11

Facts: A patient suffered serious complications during childbirth and argued that she had not been adequately informed of a material risk and an alternative treatment.

Decision: The Court held that doctors must take reasonable care to ensure patients are informed of material risks and reasonable alternatives to recommended treatment.

UK Supreme Court+1

Relevance: A neurotechnology provider offering an invasive implant or cognitive-stimulation treatment should not rely on a bare consent form if important risks, limitations, or reasonable alternatives have not been adequately explained.

Limitation: This is a medical informed-consent precedent, not a ruling about commercial ownership or licensing of neural data.

Case 5. Ohio v. American Express Co. (2018)

Supreme Court of the United States · 585 U.S. 529 (2018)

Legal issue: Whether contractual restrictions imposed by American Express on merchants violated US antitrust law.

Decision: The Court analysed the credit-card system as a two-sided transaction platform and required the competitive effects to be assessed across both sides of that market.

Supreme Court+1

Relevance: Brain-related platforms may connect device users, clinicians, researchers, developers, and advertisers. An accurate competition analysis may need to consider how restrictions affect multiple groups rather than examining one price or transaction in isolation.

For instance, a neural-device company might offer low-cost hardware while charging developers high access fees. Whether this is anticompetitive would depend on the market definition, evidence of market power, contractual restrictions, and applicable law.

Limitation: The decision does not establish special antitrust rules for neurotechnology. Its two-sided-market analysis is an analogy, and the governing legal test varies by jurisdiction.

Case 6. United States v. Microsoft Corp. (2001)

US Court of Appeals for the District of Columbia Circuit · 253 F.3d 34 (D.C. Cir. 2001)

Principle: The litigation addressed monopolisation and exclusionary conduct in software markets, including conduct associated with Microsoft's dominant position in operating systems and its treatment of competing browser technologies.

Relevance: A dominant neural-interface provider could potentially use control over its operating system, developer tools, or proprietary data formats to disadvantage competing services.

The Microsoft litigation illustrates why governance should examine whether market power is being used to exclude rivals, not merely whether a company has achieved commercial success.

Limitation: This case is not about brain technology. Any application to neural markets would require evidence and analysis under the applicable competition statute.

5. Indian statutory framework

For a Brain-Market Governance Doctrine applied in India, the following laws are particularly relevant.

Digital Personal Data Protection Act, 2023

The Act provides a framework for processing digital personal data and recognising individuals' data-protection interests. Its application to particular neural signals and derived inferences depends on whether they qualify as digital personal data and on the relevant statutory provisions.

India Code+1

An important qualification is that the Act has a phased commencement schedule. As of 29 October 2026, its provisions should not be treated as though they all commenced simultaneously. The applicable commencement notifications and rules must be checked for the specific obligation under consideration.

India Code+1

Competition Act, 2002

Suppose a dominant neurotechnology company controls the only practically usable interface for a particular class of neural implants. It refuses access to independent developers unless they accept restrictive commercial terms.

A competition-law assessment would ask:

What is the relevant product and geographic market?

Does the company hold a dominant position in that market?

Does its conduct constitute an abuse prohibited by the Competition Act?

Are the restrictions objectively justified, and what effects do they have on competitors, users, and innovation?

Dominance alone is not unlawful. Liability depends on the statutory requirements and the evidence.

6. Comparative international developments

Visit to the Colorado State Capitol | Seek Discover Learn

Colorado, United States — HB24-1058 (2024)

Colorado enacted legislation extending its privacy framework to biological data, including defined neural data generated by measuring activity in the central or peripheral nervous systems using a device. This is an important example of legislation expressly addressing neural information.

Colorado General Assembly+1

UCPlaces | Sacramento's Best: Self-Guided Driving Tour of Iconic Landmarks & History | California, United States

California, United States — neural-data privacy

California amended its consumer privacy framework in 2024 to address neural data. This development illustrates how existing personal-information laws can be adapted to cover data generated by emerging neurotechnologies. The precise obligations depend on the statutory definitions and exemptions.

PMC

París: Visita a la Sede de la UNESCO in Paris

UNESCO — Recommendation on the Ethics of Neurotechnology (2025)

UNESCO's 2025 recommendation provides an international ethical and policy framework for responsible neurotechnology development and use. It is a recommendation rather than a binding international treaty, so its principles do not automatically create directly enforceable rights in every country.

Live Law+1

7. Application to common legal disputes

The proposed doctrine becomes more useful when applied to specific scenarios.

Scenario A: Sale of neural data

A wearable-device company sells customers' neural recordings to an advertising firm.

Potential legal questions: Was the data collection and sharing lawful? Was the consent sufficiently informed? Were contractual promises or consumer-protection rules breached? Did a relevant privacy statute apply?

Possible remedies: Regulatory complaints, statutory remedies, contractual claims, or other relief available under the applicable law.

Scenario B: Workplace brain monitoring

An employer requires workers to wear devices intended to measure attention or fatigue.

Potential legal questions: Is the monitoring necessary and proportionate? Is participation genuinely voluntary? Are employment decisions based on scientifically reliable evidence? Does the practice discriminate against particular workers?

Possible safeguards: Independent validation, purpose limitation, restricted retention, meaningful alternatives, and prohibition of unjustified adverse decisions.

Scenario C: Monopoly over brain-interface software

A dominant supplier blocks rival developers from making compatible applications.

Potential legal questions: Is the restriction exclusionary? Does the supplier possess market power? Are there legitimate security or technical reasons for restricting access?

Possible safeguards: Interoperability standards, fair access terms where legally justified, portability, and competition-law enforcement.

Scenario D: Defective neural implant

An implanted device malfunctions and causes injury.

Potential legal questions: Was the device defective? Were its risks adequately disclosed? Did the manufacturer, healthcare provider, or another party breach a relevant duty? Was the product properly tested and authorised?

Possible remedies: Depending on the facts and applicable law, compensation, product-liability claims, regulatory action, or professional-negligence proceedings.

8. Proposed governance model

A workable Brain-Market Governance Doctrine could be organised around the following regulatory structure.

These are proposed governance measures, not a claim that each measure is already required by existing law.

9. A judicial test for future brain-market disputes

Courts and regulators could use the following analytical framework when interpreting existing law or considering future legislation.

Identify the activity. Determine whether the dispute concerns neural-data collection, medical treatment, cognitive enhancement, workplace monitoring, a commercial platform, or another activity.

Identify the applicable law. Establish jurisdiction, statutory coverage, the parties' legal duties, and any relevant constitutional protections.

Assess the intrusion or market harm. Examine the sensitivity of the information, physical or psychological risks, coercion, discrimination, and possible exclusionary conduct.

Examine justification and proportionality. Where relevant, assess legitimate purposes, necessity, safeguards, alternatives, and the balance between public or commercial interests and individual rights.

Determine responsibility. Identify which actors controlled the device, data, algorithms, consent process, or challenged commercial practice.

Select an effective remedy. Consider injunctions, compensation, regulatory penalties, access remedies, corrective disclosures, or other legally available relief.

This is a proposed analytical test, not an existing test adopted by a court under the name Brain-Market Governance Doctrine.

10. Critical legal challenges

Several unresolved questions will shape future governance.

Ownership: Does a person own raw neural signals, inferred mental characteristics, or both? Ownership is not the only relevant legal concept; privacy rights, licences, contractual restrictions, and data-protection duties may apply independently.

Reliability: Can an inferred mental state be measured accurately enough to justify a consequential employment, medical, or financial decision?

Consent: Can consent be genuinely voluntary when a device is necessary for work, education, treatment, or accessibility?

Commercial concentration: How should competition law address proprietary neural datasets and devices that are difficult to replace?

Cross-border governance: Which laws apply when a device collects data in India but processes it through infrastructure in another jurisdiction?

Innovation and access: How can regulation protect individuals without unnecessarily restricting beneficial research and assistive technologies?

A particularly important distinction is between recording brain activity and reliably interpreting a person's thoughts. The former does not establish that the latter is possible. Legal standards must be grounded in the actual capabilities and limitations of the technology.

11. Conclusion

The Brain-Market Governance Doctrine is best understood as a proposed framework for reconciling commercial innovation in neurotechnology with constitutional rights, privacy, safety, accountability, and fair competition.

For India, Selvi v. State of Karnataka and K.S. Puttaswamy v. Union of India provide important constitutional foundations. Montgomery offers a useful analogy for informed consent, while Ohio v. American Express and United States v. Microsoft help illuminate competition issues.

Together, these authorities can support the development of a coherent governance framework, but none independently establishes the entire doctrine. The precise legal outcome in any dispute depends on the technology, the conduct, the applicable jurisdiction, and the relevant statutory and constitutional provisions.

For a more advanced legal treatment, the next useful step would be to develop a Brain-Market Governance Accountability Doctrine with case-by-case analysis of constitutional duties, corporate liability, regulatory enforcement, and remedies.